Louis G. Lange

Insider Reports History

Entity
Individual
Location
3172 Porter Drive, Palo Alto, CA
Signature
/s/ Louise Kooij by Power of Attorney from Louis G. Lange
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Louis G. Lange:

Stock Role Class Num Shares Value Price $ Report Date Ownership
NewAmsterdam Pharma Co N.V. Director Ordinary Shares 28K $574K $20.47 Apr 14, 2025 Indirect
NewAmsterdam Pharma Co N.V. Director Ordinary Shares 10.1K $101K $10.00 Mar 26, 2025 Direct
NewAmsterdam Pharma Co N.V. Director Option (right to buy) 32.5K Jan 6, 2025 Direct
NewAmsterdam Pharma Co N.V. Director Restricted Stock Unit 137 Apr 14, 2025 Direct

Insider Reports Filed by Louis G. Lange

Symbol Company Period Transactions Value $ Form Type Date Filed Role
NAMS NewAmsterdam Pharma Co N.V. Apr 14, 2025 2 $0 4 Apr 21, 2025 Director
NAMS NewAmsterdam Pharma Co N.V. Mar 26, 2025 3 $0 4 Mar 28, 2025 Director
NAMS NewAmsterdam Pharma Co N.V. Jan 6, 2025 2 $0 4 Jan 8, 2025 Director
NAMS NewAmsterdam Pharma Co N.V. Feb 13, 2024 1 $95K 4 Feb 21, 2024 Director
NAMS NewAmsterdam Pharma Co N.V. Jan 1, 2024 1 $0 4 Jan 3, 2024 Director
NAMS NewAmsterdam Pharma Co N.V. Dec 29, 2023 0 $0 3/A Jan 25, 2024 Director
NAMS NewAmsterdam Pharma Co N.V. Dec 29, 2023 0 $0 3 Dec 29, 2023 Director
EPHY Epiphany Technology Acquisition Corp. Sep 16, 2022 0 $0 3 Oct 4, 2022 Director
BIOS BioPlus Acquisition Corp. Dec 2, 2021 0 $0 3 Dec 2, 2021 Director